Back

T cell dysregulation and remodeling in pediatric obesity and weight loss

Hay, C. A.; Sayed, S. U.; Espinoza, D. A.; Knight, M.; Abrams, E. D.; Campos Duran, J. S.; Nagy, M. Z.; Nelson, M. A.; Sheetz, S. A.; Gunnala, P.; Gonzalez, E. N. M.; Beers, J.; Tewksbury, C.; Collins, J. L.; Williams, N. N.; Lindell, R. B.; Ruffner, M. A.; Behrens, E. M.; Dumon, K. R.; Prout, E. P.; Henao-Mejia, J.; Henrickson, S. E.

2026-05-21 immunology
10.64898/2026.05.19.722395 bioRxiv
Show abstract

Obesity is a chronic inflammatory disease associated with immune dysregulation. However, alterations in adaptive immune function remain unclear, particularly in the setting of childhood obesity and weight loss. We defined peripheral T cell dysregulation in a cross-sectional cohort of pediatric participants across weight categories and in a longitudinal cohort of adolescents with severe obesity undergoing bariatric surgery. We found increased expression of activation markers (including PD-1 and CD69) in non-naive CD8+ T cells whereas non-naive CD4+ T cells were skewed towards Tfh, Th17, and mixed Th2/Th17 populations. Consistent with a hyperactive state, T cells had enhanced capacity for inflammatory cytokine production (including IFN-{gamma} and TNF-), along with enrichment of gene sets associated with cytokine signaling, cell proliferation, and cell death. Notably, these phenotypic, functional, and transcriptional alterations were not fully resolved after bariatric surgery, despite clinically meaningful weight loss. Together, these findings demonstrate that pediatric obesity leads to dysregulation of adaptive immune function with incomplete normalization after weight loss. SUMMARYThe impact of pediatric obesity on immune cell function is not well understood. This study demonstrates that both CD4+ and CD8+ T cells are dysregulated in children living with obesity and further identifies that this dysregulated state persists following clinically significant weight loss.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
JCI Insight
241 papers in training set
Top 0.1%
15.5%
2
Diabetes
53 papers in training set
Top 0.1%
10.7%
3
eLife
5422 papers in training set
Top 8%
8.9%
4
Cell Reports
1338 papers in training set
Top 5%
7.2%
5
Molecular Metabolism
105 papers in training set
Top 0.6%
3.2%
6
Journal of Clinical Investigation
164 papers in training set
Top 1%
3.2%
7
Nature Communications
4913 papers in training set
Top 43%
3.0%
50% of probability mass above
8
PLOS ONE
4510 papers in training set
Top 46%
2.2%
9
Brain, Behavior, and Immunity
105 papers in training set
Top 1%
2.0%
10
Frontiers in Immunology
586 papers in training set
Top 4%
1.6%
11
The Journal of Immunology
146 papers in training set
Top 1.0%
1.4%
12
Journal of Allergy and Clinical Immunology
25 papers in training set
Top 0.5%
1.3%
13
Journal of Neuroinflammation
50 papers in training set
Top 0.6%
1.3%
14
Scientific Reports
3102 papers in training set
Top 68%
1.0%
15
PLOS Biology
408 papers in training set
Top 15%
1.0%
16
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.7%
0.9%
17
EMBO reports
136 papers in training set
Top 5%
0.9%
18
Immunity
58 papers in training set
Top 4%
0.9%
19
Cell Reports Medicine
140 papers in training set
Top 7%
0.8%
20
Gastroenterology
40 papers in training set
Top 2%
0.8%
21
Obesity
19 papers in training set
Top 0.5%
0.8%
22
Science Translational Medicine
111 papers in training set
Top 5%
0.8%
23
International Journal of Obesity
25 papers in training set
Top 0.5%
0.8%
24
Immunology
29 papers in training set
Top 0.9%
0.8%
25
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.6%
0.8%
26
Metabolism
14 papers in training set
Top 0.4%
0.8%
27
iScience
1063 papers in training set
Top 31%
0.8%
28
BMC Medicine
163 papers in training set
Top 8%
0.7%
29
Nature Immunology
71 papers in training set
Top 2%
0.7%
30
Frontiers in Physiology
93 papers in training set
Top 6%
0.7%